The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP)

Gretchen M. Oakley*, Richard J. Harvey, Valerie J. Lund

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    36 Citations (Scopus)


    Purpose of Review: We assess the literature on the pharmacokinetics, indications, important considerations, and effectiveness of long-term, low-dose macrolide antibiotics in chronic rhinosinusitis (CRS). Recent Findings: The key to effective implementation of macrolide therapy in CRS is appropriate patient selection. Macrolides have demonstrated the most benefit in Th1-mediated non-eosinophilic CRS when used for durations of at least 3 months. Summary: Macrolide antibiotics have demonstrated great benefit when used for their anti-inflammatory or immunomodulatory properties, which include the blockage of pro-inflammatory cytokines, such as interleukin (IL)-8 and tumor necrosis factor-α (TNF-α). They have been used in CRS patients not responding to traditional corticosteroid-based treatment regimens, but appear to be most effective specifically in Th1-mediated non-eosinophilic CRS in long durations and low doses. Further research is needed to better identify characteristics known to correlate with macrolide response so early directed therapy can be implemented.

    Original languageEnglish
    Article number30
    Pages (from-to)1-10
    Number of pages10
    JournalCurrent Allergy and Asthma Reports
    Issue number5
    Publication statusPublished - May 2017


    • macrolide
    • chronic rhinosinusitis
    • sinusitis
    • non-eosinophilic
    • medical management


    Dive into the research topics of 'The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP)'. Together they form a unique fingerprint.

    Cite this